South Dakota Investment Council Grifols Sa Transaction History

South Dakota Investment Council

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$10.37 - $12.73 $727,974 - $893,646	-70,200 Reduced 81.78%	15,645 $183,000
Q4 2021 Feb 08, 2022	BUY	$10.21 - $15.27 $623,831 - $932,997	61,100 Added 246.92%	85,845 $964,000
Q2 2021 Aug 11, 2021	SELL	$16.62 - $18.94 $588,015 - $670,097	-35,380 Reduced 58.84%	24,745 $429,000
Q1 2021 May 13, 2021	SELL	$15.15 - $19.78 $334,512 - $436,742	-22,080 Reduced 26.86%	60,125 $1.04 Million
Q3 2020 Nov 06, 2020	BUY	$15.4 - $20.16 $640,640 - $838,656	41,600 Added 102.45%	82,205 $1.43 Million
Q2 2020 Aug 13, 2020	BUY	$18.24 - $21.45 $270,043 - $317,567	14,805 Added 57.38%	40,605 $741,000
Q1 2020 May 11, 2020	BUY	$16.28 - $25.63 $56,980 - $89,705	3,500 Added 15.7%	25,800 $520,000
Q4 2019 Feb 11, 2020	SELL	$19.57 - $23.52 $74,366 - $89,376	-3,800 Reduced 14.56%	22,300 $519,000
Q2 2018 Aug 13, 2018	BUY	$20.16 - $24.68 $526,176 - $644,148	26,100 New	26,100 $561,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.31B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.